Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19329| Title: | Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Aged,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Bone Neoplasms/drug therapy/secondary,Brain Neoplasms/drug therapy/secondary,Camptothecin/administration & dosage/adverse effects/analogs & derivatives,Carcinoma, Small Cell/*drug therapy/pathology,Cisplatin/administration & dosage/adverse effects,Etoposide/administration & dosage/adverse effects,Female,Humans,Liver Neoplasms/drug therapy/secondary,Lung Neoplasms/*drug therapy/pathology,Male,Maximum Tolerated Dose,Middle Aged,Survival Analysis |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/19329 |
| ISSN: | 0344-5704 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/15959778 http://www.springerlink.com/content/ll12p168562p7l16/fulltext.pdf |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Briasoulis-2005-Phase I study of eto.pdf | 376.33 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
